Regenacy Pharmaceuticals is Drug Discovery in United States that focus on histone deacetylase business. Founded in 2016. They cover business area such as developer, therapeutic drug, regeneration, normal protein function, isoform-selective histone deacetylase, inhibitor, physician, sickle cell disease, beta-thalassemia.
2016
( 8 years old in 2024 )
Histone Deacetylase
-
303 Wyman Street
Suite 300
Waltham, MA 02451
United States
Private
developertherapeutic drugregenerationnormal protein functionisoform-selective histone deacetylaseinhibitorphysiciansickle cell diseasebeta-thalassemia
* We use standard office opening hours in near Regenacy Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Regenacy Pharmaceuticals is Drug Discovery business from United States that founded in 2016 (8 years old in 2024), Regenacy Pharmaceuticals business is focusing on Histone Deacetylase.
Regenacy Pharmaceuticals headquarter office and corporate office address is located in 303 Wyman Street Suite 300 Waltham, MA 02451 United States.
Regenacy Pharmaceuticals was founded in United States.
In 2024, Regenacy Pharmaceuticals is currently focus on histone deacetylase sector.
Above is snippet of Google Trends for "histone deacetylase" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Regenacy Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
